Revolution Medicines Inc
NASDAQ:RVMD
Revolution Medicines Inc
Depreciation & Amortization
Revolution Medicines Inc
Depreciation & Amortization Peer Comparison
Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors
Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Revolution Medicines Inc
NASDAQ:RVMD
|
Depreciation & Amortization
$6.1m
|
CAGR 3-Years
18%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Depreciation & Amortization
$8.6B
|
CAGR 3-Years
2%
|
CAGR 5-Years
37%
|
CAGR 10-Years
26%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Depreciation & Amortization
$2.7B
|
CAGR 3-Years
20%
|
CAGR 5-Years
14%
|
CAGR 10-Years
18%
|
|
Amgen Inc
NASDAQ:AMGN
|
Depreciation & Amortization
$4.6B
|
CAGR 3-Years
9%
|
CAGR 5-Years
18%
|
CAGR 10-Years
12%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Depreciation & Amortization
$196m
|
CAGR 3-Years
21%
|
CAGR 5-Years
19%
|
CAGR 10-Years
14%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Depreciation & Amortization
$435.6m
|
CAGR 3-Years
21%
|
CAGR 5-Years
22%
|
CAGR 10-Years
26%
|
See Also
What is Revolution Medicines Inc's Depreciation & Amortization?
Depreciation & Amortization
6.1m
USD
Based on the financial report for Dec 31, 2023, Revolution Medicines Inc's Depreciation & Amortization amounts to 6.1m USD.
What is Revolution Medicines Inc's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 5Y
28%
Over the last year, the Depreciation & Amortization growth was 21%. The average annual Depreciation & Amortization growth rates for Revolution Medicines Inc have been 18% over the past three years , 28% over the past five years .